We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Novavax
NVAX
$2.1B
| – | – |
-56,124
| Closed | -$360K | – |
|
2152
NextCure
NXTC
$32.9M
| – | – |
-26,265
| Closed | -$151K | – |
|
2153
OmniAb
OABI
$696M
| – | – |
-4,157
| Closed | -$9.98K | – |
|
2154
O-I Glass
OI
$934M
| – | – |
-33,091
| Closed | -$380K | – |
|
2155
Omnicom Group
OMC
$21B
| – | – |
-1,608
| Closed | -$133K | – |
|
2156
Omeros
OMER
$1.44B
| – | – |
-133
| Closed | -$1.09K | – |
|
2157
Accendra Health
ACH
$32.9M
| – | – |
-428,598
| Closed | -$3.87M | – |
|
2158
OneSpan
OSPN
$671M
| – | – |
-369
| Closed | -$5.63K | – |
|
2159
Pebblebrook Hotel Trust
PEB
$2.16B
| – | – |
-17,500
| Closed | -$177K | – |
|
2160
DELISTED
Premier
PINC
| – | – |
-20,298
| Closed | -$391K | – |
|
2161
Dave & Buster's
PLAY
$240M
| – | – |
-7,928
| Closed | -$139K | – |
|
2162
Plug Power
PLUG
$2.35B
| – | – |
-1,699
| Closed | -$2.29K | – |
|
2163
CPI Card Group
PMTS
$296M
| – | – |
-20
| Closed | -$583 | – |
|
2164
Progress Software
PRGS
$1.61B
| – | – |
-163
| Closed | -$8.4K | – |
|
2165
Pyxis Oncology
PYXS
$169M
| – | – |
-2,074
| Closed | -$2.03K | – |
|
2166
QuinStreet
QNST
$900M
| – | – |
-118
| Closed | -$2.1K | – |
|
2167
DELISTED
Redfin
RDFN
| – | – |
-630,505
| Closed | -$5.81M | – |
|
2168
Ring Energy
REI
$341M
| – | – |
-727
| Closed | -$836 | – |
|
2169
Riley Exploration Permian
REPX
$1.01B
| – | – |
-20
| Closed | -$583 | – |
|
2170
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-15,819,863
| Closed | -$39.2M | – |
|
2171
Resources Connection
RGP
$98.2M
| – | – |
-330
| Closed | -$2.16K | – |
|
2172
Sinclair Inc
SBGI
$921M
| – | – |
-645
| Closed | -$10.3K | – |
|
2173
Scilex Holding
SCLX
$20.5M
| – | – |
0
| – | -$1 |
2023 Q1
9 quarters
|
|
2174
Scansource
SCSC
$1.23B
| – | – |
-214
| Closed | -$7.28K | – |
|
2175
Superior Group of Companies
SGC
$208M
| – | – |
-138
| Closed | -$1.51K | – |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.